November 19, 2013

Global spending on drugs will pass the $1 trillion mark next year, according to a new study by the IMS Institute for Healthcare Informatics, a division of healthcare market analysis firm IMS Health.

November 8, 2013

The United States is leading in its preference for generic drugs. According to a new report by Rhinebeck, N.Y.-based Phoenix Marketing International, 37% of American consumers expressed a preference for generic drugs when they were available, compared with 22% of the French, 21% of Canadians and 12% of Britons. The study was based on 810 consumers in the four countries.

November 1, 2013

A new study by IMS Health finds that most apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, with fewer than half of them directly related to patient health and treatment, and more than half of them having fewer than 500 downloads.

With more than 43,000 health-and-wellness apps from the Apple App Store alone included in the IMS study, but a dearth of apps for elderly patients with chronic conditions, there is ample opportunity for developers to address this need. That will become especially important as health care becomes increasingly focused on patient outcomes. And this means opportunities for apps that address the ever-present issue of poor medication adherence.

October 31, 2013

The "vast majority" of available mobile apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, according to a new report by IMS Health.

October 10, 2013

While the boom in generic drugs now looks set to wane, another segment of the pharmaceutical industry is rapidly rising and presenting new growth opportunities for pharmacy retailers: specialty drugs.

September 10, 2013

Ranbaxy Labs recently marked the 20th anniversary of its operations in Russia, the India-based generic drug company announced.

September 10, 2013

This year's spring allergy season has been characterized by a late start. "The allergy season was very weak in February and March, and even the beginning of April [was] very weak," William Peters, CFO and VP finance for Hi-Tech Pharmacal, told analysts in July.

September 10, 2013

What a difference a year will make. While sales of antacid tablets were down 1.3% to $2 billion for the 52 weeks ended July 14 across total U.S. multi-outlets, according to IRI, the entire category ought to have made a significant resurgence by this time next year.

August 20, 2013

It’s been a week since the National Association of Chain Drug Stores wrapped up its massive Total Store Expo pow-wow in Las Vegas. Hundreds of retail pharmacy industry vendors have broken down their exhibits and cleared the cavernous Sands Expo Center for the next big event. By last Wednesday, the exodus of more than 5,700 exhausted conference-goers from Sin City had slowed to a trickle.

August 14, 2013

IMS Health VP of supplier services Jim Hunter and IMS VP of industry relations Doug Long presented Rite Aid EVP of pharmacy Robert Thompson with IMS' Bernie Greenberg Pharmacy Partnership Award at the NACDS Total Store Expo.

August 12, 2013

This year, generic drugs account for 83% of all drugs dispensed in the United States, and that figure is set to get even larger over the next few years. That was among the takeaways from IMS Health VP industry relations Doug Long’s presentation Sunday morning.

August 8, 2013

The world is turning generic. That's the takeaway from the latest trends in the drug industry, according to IMS Health.

August 6, 2013

It’s show time! Jam-packed with all of the excitement that is Las Vegas, the National Association of Chain Drug Stores Total Store Expo has officially kicked off. As you gear up for the next few days and embark on this game-changing event, DSN has compiled a list of 10 key things to do at NACDS TSE.

June 19, 2013

More responsible use of drugs could save the U.S. healthcare system more than $200 billion per year, according to a new study by the research arm of IMS Health.

May 31, 2013

Out of all retail pharmacy outlets, food stores have slightly increased their prescription sales, generating March year-to-date sales of $5.7 billion, up 0.5%, according to IMS Health data. Including drug, mail and independents, prescription sales totaled $58.3 billion, down 4.7%, reported Doug Long, VP industry relations for IMS Health, at an FMI education breakout.

May 9, 2013

Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

May 9, 2013

The November 2011 expiration of Pfizer's patent on the cholesterol drug Lipitor and Ranbaxy Labs' release of the generic version received significant play in the media, particularly due to the theretofore status of Lipitor (atorvastatin calcium) as the drug with the highest sales in the country, $7.7 billion in the United States, according to healthcare analytics firm IMS Health.

May 3, 2013

Healthcare analytics firm IMS Health has acquired social media analytics company Semantelli Corp., saying the purchase would allow it to provide real-time monitoring and delivery of insights into consumer and physician behavior and sentiments.

May 1, 2013

Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

April 30, 2013

The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.

April 19, 2013

President Barack Obama sent his $3.8 trillion budget proposal to Congress on April 10, and the plan includes a number of provisions designed to cut spending on health care and promote health and wellness.

Overall, the budget is something of a mixed bag for the healthcare industry. While it would provide incentives for expanding the use of generic drugs, for example, it would also cut spending on Medicaid that have drawn opposition from pharmacy retailers, and even generic drug makers disagree with some of its provisions for that industry.

April 16, 2013

Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.

April 11, 2013

Research has indicated that about half of antibiotic prescriptions are unnecessary, raising concerns about the growth of bacteria resistant to them, but a new study by researchers at the Centers for Disease Control and Prevention also finds that prescriptions are highest in several states in the South and Midwest.

April 8, 2013

A growing number of patients on Medicaid are filling their prescriptions through Managed Medicaid plans instead of the fee-for-service model as states switch them over in an effort to improve patient care and cut healthcare costs, but the effects remain unclear, according to a new study.